Synthetic and Natural Cannabinoids: the Cardiovascular Risk

Synthetic and Natural Cannabinoids: the Cardiovascular RiskFrom The British Journal of Cardiology, this 2015 editorial, by neurologist and cannabis research pioneer Dr. Ethan Russo, explores the cardiovascular risks associated with cannabis, suggesting that ultra-low THC and therapeutic phytocannabinoid dosing are cardio protective, while high doses of THC and high levels of stimulation of the CB1 receptor pose cardiovascular risks. (more…)

Psychosis and High Potency Cannabis

Psychosis and High Potency Cannabis - 2015 Study

Published in the February 2015 issue of Lancet Psychiatry is this study looking at psychosis linked to use of potent cannabis. The risk of individuals having a psychotic disorder showed a roughly three-times increase in users of skunk-like cannabis compared with those who never used cannabis. (more…)

THC Reduces Human Breast Cancer Cell Proliferation

THC Reduces Human Breast Cancer Cell Proliferation THC and breast cancer – Little is known about the effect of cannabinoids on the cell cycle, the main process controlling cell fate. This study out of Spain, published in a 2006 issue of Cancer Research, shows that Δ9-tetrahydrocannabinol (THC), through activation of CB2 cannabinoid receptors, reduces human breast cancer cell proliferation by blocking the progression of the cell cycle and by inducing apoptosis
(more…)

Medical Cannabis Strain Content Satisfaction

Medical Cannabis Strain Content Satisfaction

This study, published in the June 2014 issue of the Journal of Clinical Psychopharmacology, describes more than 100 patients reporting about the therapeutic satisfaction with their pharmaceutical-grade cannabis product. Furthermore, differences in subjective effects among the available strains are investigated. (more…)

Page 1 of 512345